The intrathoracic lymph node ratio seems to be a better prognostic factor than the level of lymph node involvement in lung metastasectomy of colorectal carcinoma

Interactive Cardiovascular and Thoracic Surgery

Volumn 20, Issue 2, 2015, Pages 215-221

  Renaud, Stéphane ^a   Falcoz, Pierre Emmanuel ^a   Olland, Anne ^a   Schaeffer, Mickal ^b   Reeb, Jérémie ^a   Santelmo, Nicola ^a   Massard, Gilbert ^a  

^a HÔPITAL CIVIL   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Colorectal metastases; Lung metastasectomy; Thoracic lymph nodes

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ARTICLE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RECURRENCE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HAZARD RATIO; HEALTH STATUS; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INTRATHORACIC LYMPH NODE RATIO; LIVER METASTASIS; LOBECTOMY; LOCAL RECURRENCE FREE SURVIVAL; LUNG METASTASIS; LUNG PARENCHYMA; LUNG RESECTION; LUNG SURGERY; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PREOPERATIVE PERIOD; RECTUM TUMOR; RECURRENT LARYNGEAL NERVE PALSY; RETROSPECTIVE STUDY; RISK REDUCTION; SEGMENTECTOMY; SURGICAL MORTALITY; TREND STUDY; UNIVARIATE ANALYSIS; ADVERSE EFFECTS; AGED; CARCINOMA; COLORECTAL TUMOR; KAPLAN MEIER METHOD; LUNG NEOPLASMS; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; METASTASIS RESECTION; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SECONDARY; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; CARCINOMA; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; METASTASECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PNEUMONECTOMY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84922449485     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivu364     Document Type: Article

References (24)

1. Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW. Colorectal cancer. Lancet 2005;365:153-65.
2. August DA, Ottow RT, Sugarbaker PH. Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev 1984;3:303-24.
3. McCormack PM, Burt ME, Bains MS, Martini N, Rusch VW, Ginsberg RJ. Lung resection for colorectal metastases. 10-year results. Arch Surg 1992; 127:1403-6.
4. Baron O, Amini M, Duveau D, Despins P, Sagan CA, Michaud JL. Surgical resection of pulmonary metastases from colorectal carcinoma. Five-year survival and main prognostic factors. Eur J Cardiothorac Surg 1996;10:347-51.
5. Girard P, Ducreux M, Baldeyrou P, Rougier P, Le Chevalier T, Bougaran J, et al. Surgery for lung metastases from colorectal cancer: analysis of prognostic factors. J Clin Oncol 1996;14:2047-53.
6. Okumura S, Kondo H, Tsuboi M, Nakayama H, Asamura H, Tsuchiya R, et al. Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients. J Thorac Cardiovasc Surg 1996;112:867-74.
7. Zanella A, Marchet A, Mainente P, Nitti D, Lise M. Resection of pulmonary metastases from colorectal carcinoma. Eur J Surg Oncol 1997;23:424-7.
8. Poon MA, O'Connell MJ, Moertel CG, Wieand HS, Cullinan SA, Everson LK, et al. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 1989;7:1407-18.
9. Adam R, de Haas RJ, Wicherts DA, Vibert E, Salloum C, Azoulay D, et al. Concomitant extrahepatic disease in patients with colorectal liver metastases: when is there a place for surgery?. Ann Surg 2011;253:349-59.
10. Hamaji M, Cassivi SD, Shen KR, Allen MS, Nichols FC, Deschamps C, et al. Is lymph node dissection required in pulmonary metastasectomy for colorectal adenocarcinoma?. Ann Thorac Surg 2012;94:1796-800.
11. Sclafani F, Incarbone M, Rimassa L, Personeni N, Giordano L, Alloisio M, et al. The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer. J Thorac Cardiovasc Surg 2013;145:97-103.
12. Zabaleta J, Aguinagalde B, Fuentes MG, Bazterargui N, Izquierdo JM, Hernandez CJ, et al. Survival after lung metastasectomy for colorectal cancer: importance of previous liver metastasis as a prognostic factor. Eur J Surg Oncol 2011;37:786-90.
13. Riquet M, Foucault C, Cazes A, Mitry E, Dujon A, Le Pimpec Barthes F, et al. Pulmonary resection for metastases of colorectal adenocarcinoma. Ann Thorac Surg 2010;89:375-80.
14. Saito Y, Omiya H, Kohno K, Kobayashi T, Itoi K, Teramachi M, et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardiovasc Surg 2002;124:1007-13.
15. Jonnalagadda S, Arcinega J, Smith C, Wisnivesky JP. Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer. Cancer 2011;117:4724-31.
16. Nwogu CE, Groman A, Fahey D, Yendamuri S, Dexter E, Demmy TL, et al. Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer. Ann Thorac Surg 2012;93:1614-9; discussion 1619-1620.
17. Urban D, Bar J, Solomon B, Ball D. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer. J Thorac Oncol 2013;8:940-6.
18. Wang CL, Li Y, Yue DS, Zhang LM, Zhang ZF, Sun BS. Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients. World J Surg 2012;36:455-62.
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
20. Inoue M, Ohta M, Iuchi K, Matsumura A, Ideguchi K, Yasumitsu T, et al. Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. Ann Thorac Surg 2004;78:238-44.
21. Pfannschmidt J, Muley T, Hoffmann H, Dienemann H. Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: experiences in 167 patients. J Thorac Cardiovasc Surg 2003;126:732-9.
22. Fukui T, Mori S, Yokoi K, Mitsudomi T. Significance of the number of positive lymph nodes in resected non-small cell lung cancer. J Thorac Oncol 2006;1:120-5.
23. Gonzalez M, Poncet A, Combescure C, Robert J, Ris HB, Gervaz P. Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review andmeta-Analysis. Ann Surg Oncol 2013;20:572-9.
24. Treasure T, Fallowfield L, Farewell V, Ferry D, Lees B, Leonard P, et al. Pulmonary metastasectomy in colorectal cancer: time for a trial. Eur J Surg Oncol 2009;35:686-9.